Watch What They Do, Not What They Say (RealMoney Silver $)
Secondary season is off with a bang!
05:09PM 09/08/09
Dendreon, Vion and Allos: Biotech Mailbag
Take profits on Vion Pharmaceuticals; nothing to worry about in Dendreon's dip; still bullish on Allos Therapeutics; YM Biosciences is too much loved.
07:00AM 08/14/09
Feuerstein's Biotech-Stock Mailbag: Titan, Gilead
Why Titan Pharma needs a development partner. And disparate outlooks for Gilead, Vanda and YM BioSciences.
11:03AM 08/08/08
Biotech-Stock Mailbag: Titan, Gilead (RealMoney.com $)
Why Titan Pharma needs a development partner. And disparate outlooks for Gilead, Vanda and YM BioSciences.
07:00AM 08/08/08
Feuerstein's Biotech-Stock Mailbag: Synta
Synta's chances with elesclomal, Vanda's chances with Fanapta, the Immunogen-Genentech connect, and more.
11:07AM 07/18/08
Biotech-Stock Mailbag: Synta, Vanda (RealMoney.com $)
Synta's chances with elesclomal, Vanda's chances with Fanapta, the Immunogen-Genentech connect, and more.
07:01AM 07/18/08
Feuerstein's Biotech-Stock Mailbag: Delcath
More discussion of Sangamo's SB-509, revisiting Delcath and questioning YM Bio's chances with nimo.
10:03AM 06/27/08
Biotech-Stock Mailbag: Sangamo, YM Biosciences (RealMoney.com $)
More discussion of Sangamo's SB-509, revisiting Delcath and questioning YM Bio's chances with nimo.
07:03AM 06/27/08
Biotech Notebook: Vertex, Medicines Co.
Uncertain regulation hangs on Vertex's telaprevir, The Medicines Co. remains mum on Cleviprex and a summer biotech-stock watch list.
10:09AM 06/10/08
Do These Biotech Dogs Still Have Legs?
Three once-promising stocks have been hit hard recently, leaving few reasons to believe.
09:23AM 02/08/08
News You Need: Wachovia, Disney
Companies making headlines today include Wachovia and Disney.
05:59AM 02/08/08
Thursday's Health Winners & Losers
Altus got its hormone drug, but gave up 40% in the market.
02:16PM 12/20/07
Tuesday's Late Winners & Losers
Finisar and Guess? were among the after-hours losers.
07:17PM 09/04/07
The company is cleared to start a phase II trial for its pediatric brain cancer treatment.
07:18PM 08/30/07



Connect with TheStreet